ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Vitrakvi 25 mg, Kapseln - 56
67281001 Bayer (Schweiz) AG
Vitrakvi 25 mg, Kapseln28.05.2020
  28.05.2020
Larotrectinib (L01EX12) 
WHO-DDD19.02.2029
07.16.10.56
07.16.10. 
A  
Yes 
IPCI
1351.24Yes
    
10 %1485.95
  
7680672810010Synthetika
  
Composition
larotrectinibum 25 mg ut larotrectinibi sulfas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 132, E 171, propylenglycolum, dimeticonum 1000, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Larotrectinibum25 mg
BAG: Active AgentDose
Larotrectinibum25 mg
 
Inactive agentsDoseadditional_information
Dimeticone1000  
E 132 color.
E 171 color.
Gelatina Kapselhülle
Lacca Drucktinte
Pro Capsula  
Propylenglycol  
 
Source
Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home